Dysregulation of FXR signaling has been linked to metabolic diseases such as obesity, type 2 diabetes, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis [64,65]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.